{"id":533624,"date":"2021-09-02T07:03:21","date_gmt":"2021-09-02T11:03:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/"},"modified":"2021-09-02T07:03:21","modified_gmt":"2021-09-02T11:03:21","slug":"autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/","title":{"rendered":"Autolus Therapeutics to participate in upcoming virtual investor conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>&#8211; Goldman Sachs Eleventh Annual Biotech Symposium on September 7<\/p>\n<p><\/em><br \/>\n        <em>&#8211; 2021 <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4xW32cyew2VhHOEB6qMg2LqC_uFy1keb06IfBcFrzmDBzPVerNvSsxfyhAiUX0VNLEtRQP-_Ft-DucEFD0jgXez2QbDB5JMKCh_f7OaoP3gaK0wgayZZ-rZITmI48D3toJy_ct6yuAFWOj6lSb3r6jtBP015R3qof84fWdmZJI4vjb8AVnYFSV4FBr1ApuNCSHbhwl6oSiHqO9SuYYVI1Q==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <em>Virtual Wells Fargo Healthcare Conference<\/em><br \/>\n        <\/a><br \/>\n        <em>on September 10 at 7.30am ET<\/em>\n      <\/p>\n<p align=\"center\">\n        <em>&#8211; H.C. Wainwright &amp; Co 23rd Annual Global Investment Conference on September 13, at 7.00am ET<\/em>\n      <\/p>\n<p align=\"justify\">LONDON, Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of any presentations will be available live. You can access the webcasts via the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q6bV2titz3dU1c1WsxwQbOoJby9PFAFiHlU7bHfD22BCve1arveF7f_a-Ja4MHPpANYJCl-JneTz7Ec57zztULwzp3URpbdvie9IiIJmnBno9URTr5ial30vGvtsk868\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a> section of the Autolus website. An archived version will also be available through the Company\u2019s website for a limited time following the conference.<\/p>\n<p align=\"justify\">\n        <strong>About Autolus Therapeutics plc<\/strong><br \/>\n        <br \/>Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5dbC-CFl6o31ZHVF7ZVHo4jvbRcjkqX3RH6xobfQGPpdnajjGZ0Vw31edACFOy6GPoOrmL_wW1qSvKO4ltNQSA==\" rel=\"nofollow noopener\" target=\"_blank\">www.autolus.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact: <\/strong>\n      <\/p>\n<p align=\"justify\">Lucinda Crabtree, PhD<br \/>Vice President, Business Strategy and Planning<br \/>+44 (0)\u00a07587 372 619\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IJTwXXebOTTpWDve46nTmicVtGU4TNekGvpVFbXPxOBbaHVBEKiBPR4gMeNnRo4r5yXgs3hu6H-mkWIXX9fC2fKKFkaYNFMkpoMnI5jYQL8=\" rel=\"nofollow noopener\" target=\"_blank\">l.crabtree@autolus.com<\/a><\/p>\n<p align=\"justify\">Julia Wilson<br \/>+44 (0) 7818 430877<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c9dwOOd4Zg5F8uz9OR9SNqBJieNqEpASCvHFjcELs1D-s0MAVJ5u8whAnXz3N2OLPu3CwJYfm_K0reT6CjiEUMASbAk2WT30X5TcXu93RG0=\" rel=\"nofollow noopener\" target=\"_blank\">j.wilson@autolus.com<\/a><\/p>\n<p align=\"justify\">Susan A. Noonan<br \/>S.A. Noonan Communications<br \/>+1-212-966-3650<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IMQHB9T4uLgh2014lQt1xw6swHrevvSofxKJksJPMXCoW9Gjav94xLMIQoYnRyQx6h6L_BpkXWGT2r0mhGQcgP_ZmI9vzNZLHWSKq9XbwCc=\" rel=\"nofollow noopener\" target=\"_blank\">susan@sanoonan.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTg0YjhiYzAtMzI1MS00NGExLTkyNjYtZDA3MGJiZmM5NDg4LTExMjIwMDA=\/tiny\/Autolus-Limited.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#8211; Goldman Sachs Eleventh Annual Biotech Symposium on September 7 &#8211; 2021 Virtual Wells Fargo Healthcare Conference on September 10 at 7.30am ET &#8211; H.C. Wainwright &amp; Co 23rd Annual Global Investment Conference on September 13, at 7.00am ET LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of any presentations will be available live. You can access the webcasts via the Events section of the Autolus website. An archived version will also be available through the Company\u2019s website for a limited time following the conference. About Autolus Therapeutics plc Autolus is a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Autolus Therapeutics to participate in upcoming virtual investor conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533624","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autolus Therapeutics to participate in upcoming virtual investor conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autolus Therapeutics to participate in upcoming virtual investor conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"&#8211; Goldman Sachs Eleventh Annual Biotech Symposium on September 7 &#8211; 2021 Virtual Wells Fargo Healthcare Conference on September 10 at 7.30am ET &#8211; H.C. Wainwright &amp; Co 23rd Annual Global Investment Conference on September 13, at 7.00am ET LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of any presentations will be available live. You can access the webcasts via the Events section of the Autolus website. An archived version will also be available through the Company\u2019s website for a limited time following the conference. About Autolus Therapeutics plc Autolus is a &hellip; Continue reading &quot;Autolus Therapeutics to participate in upcoming virtual investor conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autolus Therapeutics to participate in upcoming virtual investor conferences\",\"datePublished\":\"2021-09-02T11:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/\"},\"wordCount\":239,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/\",\"name\":\"Autolus Therapeutics to participate in upcoming virtual investor conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=\",\"datePublished\":\"2021-09-02T11:03:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autolus Therapeutics to participate in upcoming virtual investor conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autolus Therapeutics to participate in upcoming virtual investor conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Autolus Therapeutics to participate in upcoming virtual investor conferences - Market Newsdesk","og_description":"&#8211; Goldman Sachs Eleventh Annual Biotech Symposium on September 7 &#8211; 2021 Virtual Wells Fargo Healthcare Conference on September 10 at 7.30am ET &#8211; H.C. Wainwright &amp; Co 23rd Annual Global Investment Conference on September 13, at 7.00am ET LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Autolus Therapeutics plc\u00a0(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of any presentations will be available live. You can access the webcasts via the Events section of the Autolus website. An archived version will also be available through the Company\u2019s website for a limited time following the conference. About Autolus Therapeutics plc Autolus is a &hellip; Continue reading \"Autolus Therapeutics to participate in upcoming virtual investor conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:03:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autolus Therapeutics to participate in upcoming virtual investor conferences","datePublished":"2021-09-02T11:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/"},"wordCount":239,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/","name":"Autolus Therapeutics to participate in upcoming virtual investor conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=","datePublished":"2021-09-02T11:03:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQwNiM0Mzg2Nzc1IzIxMTA0Mjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autolus-therapeutics-to-participate-in-upcoming-virtual-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autolus Therapeutics to participate in upcoming virtual investor conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533624"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533624\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}